Article Information
- Received February 1, 2012
- Revision received February 25, 2012
- Accepted February 29, 2012
- First published April 11, 2012.
- Version of record published April 11, 2012.
Author Information
Author contributions
Author contributions: H.A., K.D., U.A.N., O.L., and Z.K. designed research; H.A., K.D., E.M., K.O., S.W., V.D., R.E.I., O.T., J.C.W., S.B., L.J., and Z.K. performed research; E.E. and S.-E.W.J. contributed unpublished reagents/analytic tools; H.A., K.D., E.M., K.O., S.W., R.I., J.C.W., S.B., L.J., U.A.N., O.L., and Z.K. analyzed data; H.A., K.D., U.A.N., O.L., and Z.K. wrote the paper.
Disclosures
- Received February 1, 2012.
- Revision received February 25, 2012.
- Accepted February 29, 2012.
This work was supported by the Swedish Research Council, EU project LSHB-CT-2006-037526 (STEMSTROKE), EU 7th work program through the European Stroke Network (Grant no. 201024), AFA Foundation, and Swedish Government Initiative for Strategic Research Areas (StemTherapy).We thank Drs. W. Tong and H. Lodish for providing the retroviral constructs, Dr. L. Velazquez for providing Lnk antibody, Drs. L. Aigner, S. Couillard-Despres, L. Pevny, and S. Kohsaka for providing transgenic mice, Zhi Ma and Teona Roschupkina for help with cell sorting, Marianne Rissler for virus production, and Camilla Ekenstierna for technical assistance.
The authors declare no conflict of interest.
- Correspondence should be addressed to Dr. Zaal Kokaia, Laboratory of Neural Stem Cell Biology and Therapy, Lund Stem Cell Center, Lund University Hospital, SE- 221 84 Lund, Sweden. Zaal.Kokaia{at}med.lu.se
Online Impact